Understanding Myelodysplastic Syndromes (MDS)

Jun 20, 2024

Understanding Myelodysplastic Syndromes (MDS)

What is MDS?

  • Group of bone marrow failure disorders
  • Bone marrow doesn't produce enough healthy blood cells
  • Considered a form of blood cancer, can turn into leukemia

Function of Bone Marrow

  • Tissue in bones that makes blood cells
  • Produces stem cells (immature cells)
  • Stem cells mature into:
    • Red blood cells (carry oxygen)
    • White blood cells (fight infection)
    • Platelets (help stop bleeding)

MDS Mechanics

  • Stem cells may remain as immature cells (blasts) or develop abnormally
  • Leads to too few healthy mature blood cells (cytopenia)
  • Types of cytopenia:
    • Anemia: too few red blood cells
    • Neutropenia: too few white blood cells
    • Thrombocytopenia: too few platelets

Causes of MDS

  • Alteration in bone marrow cells, affects DNA instructions
  • Often unknown cause
  • Risk factors:
    • Age over 60
    • Previous chemotherapy or radiation
    • Exposure to certain chemicals
    • Smoking

Symptoms of MDS

  • Vary by individual and affected blood cells
  • Common symptoms:
    • Fatigue
    • Shortness of breath
    • Heart palpitations
    • Fever or infections
    • Bleeding or bruising easily
  • Sometimes asymptomatic

Diagnosis

  • Routine blood test (Complete Blood Count)
  • Counts red and white blood cells, platelets

Genetic Factors

  • Rarely inherited
  • Related to genetic changes in DNA
  • No specific prevention methods
  • Risk can be lowered by:
    • Not smoking
    • Avoiding cancer-causing chemicals
    • Avoiding heavy metals (lead, mercury)
    • Avoiding radiation, certain chemotherapy drugs

Types of MDS

  • Based on appearance, number of abnormal cells (blasts), and genetic abnormalities
  • MDS type may change with progression
  • Scoring system to classify severity:
    • Five categories: Very Low to Very High

Treatment and Prognosis

  • Low/Very Low score: May not need treatment for years
  • Intermediate/High/Very High score: May need immediate treatment
  • 30% risk of developing acute myeloid leukemia (AML)
  • Chemotherapy may help for intermediate/high risk
  • High/Very High risk prognosis: 1-2 years without treatment
  • Lower risk scores: Better prognosis
  • Symptom level affects prognosis

Importance of Understanding MDS

  • Learn about type and risk group
  • Better information leads to better treatment decisions